Jifang Zhou

Jifang Zhou

University of Illinois at Chicago

H-index: 13

North America-United States

About Jifang Zhou

Jifang Zhou, With an exceptional h-index of 13 and a recent h-index of 13 (since 2020), a distinguished researcher at University of Illinois at Chicago, specializes in the field of Cancer, Blood disorders, Comparative effectiveness research, HEOR, Health Services Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PO2-04-02: Trends in Disparities and Transitions of target therapy in Patients With ERBB2 Positive Early Breast Cancer in China and the US, 2011 to 2021

Incidence, risk factors, and outcomes of chylothorax after cardiac procedure in the United States

Contemporary Comparative Surgical Outcomes of Type A Aortic Dissection in US and China: an Analysis of the National Inpatient Sample Database and a Chinese Multi-Institutional …

Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series …

Elevated respiratory complications following robotic‐assisted lobectomy: A national cohort analysis of 26,140 cases

Clinical Outcomes, Management, Healthcare Resource Utilization, and Cost According to the CHA2DS2-VASc Scores in Asian Patients with Nonvalvular Atrial Fibrillation

Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study

Jifang Zhou Information

University

Position

___

Citations(all)

607

Citations(since 2020)

540

Cited By

231

hIndex(all)

13

hIndex(since 2020)

13

i10Index(all)

16

i10Index(since 2020)

16

Email

University Profile Page

Google Scholar

Jifang Zhou Skills & Research Interests

Cancer

Blood disorders

Comparative effectiveness research

HEOR

Health Services Research

Top articles of Jifang Zhou

Abstract PO2-04-02: Trends in Disparities and Transitions of target therapy in Patients With ERBB2 Positive Early Breast Cancer in China and the US, 2011 to 2021

Cancer Research

2024/5/2

Incidence, risk factors, and outcomes of chylothorax after cardiac procedure in the United States

Heliyon

2024/4/7

Contemporary Comparative Surgical Outcomes of Type A Aortic Dissection in US and China: an Analysis of the National Inpatient Sample Database and a Chinese Multi-Institutional …

2024/3/14

Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis

Catheterization and Cardiovascular Interventions

2024/2/14

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series …

Frontiers in Pharmacology

2024/2/8

Elevated respiratory complications following robotic‐assisted lobectomy: A national cohort analysis of 26,140 cases

The International Journal of Medical Robotics and Computer Assisted Surgery

2024/2

Clinical Outcomes, Management, Healthcare Resource Utilization, and Cost According to the CHA2DS2-VASc Scores in Asian Patients with Nonvalvular Atrial Fibrillation

medRxiv

2024

Yue Xiao
Yue Xiao

H-Index: 1

Jifang Zhou
Jifang Zhou

H-Index: 7

Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study

2023/10/13

Comparative Analysis of Patient Characteristics, BTK Treatment, and Treatment Outcomes in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Cross-National …

Blood

2023/12/1

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis …

Frontiers in Oncology

2023

Association of COVID-19 Policy Stringency on Patient Satisfaction with Community Pharmacy in China: A Cross-sectional Standardized Patient Study

2023/10/4

Association Between Traditional Chinese Medicine and Medication Adherence in Hypertensive Patients in Mainland China: A Real-World Population-Based Cohort Study

2023/9/15

Development and validation of a patient satisfaction survey for pharmaceutical service at primary care settings

Journal of managed care & specialty pharmacy

2016/1

Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021

JAMA Network Open

2023/6/1

Effectiveness of prophylactic use of hepatoprotectants for tuberculosis drug-induced liver injury: a population-based cohort analysis involving 6,743 Chinese patients

Frontiers in Pharmacology

2022/4/20

Association between hypernatremia and delirium after cardiac surgery: a nested case-control study

Frontiers in Cardiovascular Medicine

2022/3/8

Liang Hong
Liang Hong

H-Index: 10

Jifang Zhou
Jifang Zhou

H-Index: 7

Setting: Programmatic management of drug-resistant tuberculosis in Ningbo, China. Objective: To assess whether data-driven genetic determinants of drug resistance patterns …

Evidence-based Medicine to Inform Practice: Assessing Clinical Effectiveness and Economic Burden of Medicine

2022/3/8

Use of unannounced standardized patient to assess quality of care in community pharmacies/medicine shops: a pilot, cross-sectional study

2022

Rajeev Shrestha
Rajeev Shrestha

H-Index: 4

Jifang Zhou
Jifang Zhou

H-Index: 7

Serious opioid-related adverse outcomes associated with opioids prescribed by dentists

Pain

2022/8/1

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey

Journal of Patient Experience

2022/7

Jifang Zhou
Jifang Zhou

H-Index: 7

See List of Professors in Jifang Zhou University(University of Illinois at Chicago)

Co-Authors

academic-engine